| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Tetrault Lynn A. is a Director at NEOGENOMICS INC with holdings across 2 companies. Recent SEC Form 4 filings include 3 buys and 11 sells.
Estimated insider holdings value: $1.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 9, 2025 | NEO Neogenomics Inc | Director | Buy | 7,000 | $8.14 | $56,974.40 | New | -28.4% | +11.3% | |
| Sep 10, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | Director | Sale+OE | 20,700 | $49.71 | $1,028,991.13 | -49.2% | +16.9% | +104.3% | |
| Aug 26, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | Director | Sale+OE | 4,300 | $50.01 | $215,028.81 | -58.9% | +19.8% | +102.4% | |
| Aug 12, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | Director | Sale+OE | 10,000 | $44.65 | $446,461.81 | -60.9% | +47.4% | +116.9% | |
| Mar 4, 2024 | NEO Neogenomics Inc | Director | Sell | 6,112 | $15.97 | $97,578.69 | -10.9% | -15.9% | -41.9% | |
| Nov 19, 2018 | NEO Neogenomics Inc | Director | Sell | 13,000 | $16.00 | $207,940.00 | -14.2% | - | - | |
| Nov 14, 2018 | NEO Neogenomics Inc | Director | Sale+OE | 5,000 | $16.16 | $80,800.00 | -8.9% | - | - | |
| Dec 21, 2015 | NEO Neogenomics Inc | Director | Buy | 9,500 | $8.21 | $77,995.00 | +187.7% | - | - | |
| Dec 7, 2015 | NEO Neogenomics Inc | Director | Buy | 3,500 | $7.72 | $27,020.00 | +224.4% | - | - |